Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.

The Journal of infectious diseases - 1 Mar 2016

Beck Hans-Peter, Wampfler Rahel, Carter Nick, Koh Gavin, Osorio Lyda, Rueangweerayut Ronnatrai, Krudsood Srivcha, Lacerda Marcus V, Llanos-Cuentas Alejandro, Duparc Stephan, Rubio Justin P, Green Justin A

Abstract excerpt

UNLABELLED: Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of genetically heterologous or homologous P. vivax infection recurrence following receipt of chloroquine plus one of 4 doses of tafenoquine (50, 100,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoquinolines
Share to Antimalarials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chloroquine

Share to Dose-Response Relationship, Drug

Share to Double-Blind Method

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 26500351
DOI: 10.1093/infdis/jiv508
PMCID: PMC4747625

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.PMID 26500351Read ↗

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.Semantic proximity Read ↗

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directionsSemantic proximity Read ↗

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.Semantic proximity Read ↗

Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.Semantic proximity Read ↗

Differential impact of Tafenoquine and Primaquine on Plasmodium vivax recurrence: the role of CYP2D6 variants.Semantic proximity Read ↗

Estimating the probable cause of recurrence in Plasmodium vivax malaria: relapse, reinfection or recrudescence?Semantic proximity Read ↗

Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineagesSemantic proximity Read ↗

Impact of CYP2D6 Genetic Variation on Radical Cure of Plasmodium vivax Malaria.Semantic proximity Read ↗

Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineagesSemantic proximity Read ↗

Microhaplotype deep sequencing assays to capture<i>Plasmodium vivax</i>infection lineagesSemantic proximity Read ↗

Revisiting <i>Plasmodium vivax</i> molecular correctionSemantic proximity Read ↗

Relapses of<i>Plasmodium vivax</i>Infection Usually Result from Activation of Heterologous HypnozoitesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.